Innovative solutions
Expanding drug development capabilities to better solve your biggest challenges
$2.3 billion
Average cost of developing a new drug rose to $2.3 billion in 2022, making the CDMO partner you choose a critical investment1
Drug developers face an increasingly complex landscape. The pipeline has become more complex, with double-digit growth for specialty drugs such as biologics, orphan drugs, and cell and gene therapies. More therapies—including large molecule drugs, small molecule drugs, and advanced therapies—are also following expedited approval processes. Returns on research and development are declining, driving an urgent need for speed, efficiency, and effectiveness. Success rests upon expertise, agility, and capacity.
We are responding with innovations and investments to expand our expertise, capacity, and capabilities from early phase to commercialization. Our aim is to enhance your productivity and scalability—whether you’re an emerging biotech working on a vaccine for a novel virus or a high-volume pharmaceutical manufacturer delivering necessary drugs at scale.
Discover our end-to-end innovative solutions
Digital transformation and enablement
To help our clients meet the demands of the increasingly digital world, we are responding with innovations that push the limits of efficiency, agility, and quality for our customers as we adopt networked systems, data analytics, and advanced automation. Offerings such as our mysupply digital supply chain platform, real-time track and trace, trial setup and planning and direct-to-patient decentralized trial services are paving the way forward.
Integrated CDMO offerings
We offer an end-to-end suite of drug development and clinical services, including drug substance and product manufacturing for small molecules, large molecules, and advanced therapies, along with clinical supply, clinical research, and commercialization services. Our unique approach ensures shared accountability throughout the drug development journey, enhancing speed, simplicity, and scalability at every step.
Pharmaceutical manufacturing
The growing market demands a shift in capacity, driven by advances in bioprocesses and capabilities—as well as a focus on smaller, niche populations. Our innovative manufacturing solutions include continuous manufacturing, where we move materials non-stop through an integrated equipment train to eliminate the hold times between processing steps. The result is reduced API usage and shorter timelines.
Supply chain and speed to market
Maintaining supply chain continuity has never been more critical, and pharma companies everywhere are exploring ways to increase efficiency. We protect product integrity throughout your supply chain or cold chain with our world-class total transportation management, storage, and distribution services. Our global expertise in technology transfers can help you quickly and reliably scale up production or shift production between sites.
View references